New research tracks tick distribution and rising disease risk across Wisconsin
While most people dread finding a tick stuck to their clothing or skin, Johnny Uelmen is literally beating the bushes for them.
UW spinoff company launches clinical trial for metastatic cancer treatment
The first patient in a clinical trial led by Archeus Technologies has received a dose of an investigational therapy to treat metastatic cancer, developed by the clinical-stage company which has ties to the University of Wisconsin–Madison, UW Health’s Isthmus Project and the Wisconsin Alumni Research Foundation.
Research agreement signed with Accuray to improve personalized cancer care
A new 10‑year strategic collaboration between the University of Wisconsin School of Medicine and Public Health and Accuray Incorporated will support clinical research, education and training, and development of adaptive therapies that help empower medical care teams to continually raise the standard in cancer care.
Collaborative research effort reveals biomarkers for Huntington’s disease
Two UW professors collaborated to analyze a large dataset from PREDICT-HD, one of the largest studies of early Huntington’s disease ever conducted.
Scientists discover molecular mechanism that could boost calorie burning
GLP-1 drugs have transformed weight loss by suppressing appetite. The other half of the equation — helping the body burn more energy — has received less attention.
Clinical trial tests new cell therapy to manage kidney transplant rejection
A first-of-its-kind clinical trial at the Program for Advanced Cell Therapy will examine a new method to manage kidney rejection following transplant.
Eight researchers transforming colorectal cancer care
March is National Colorectal Cancer Awareness Month, established to raise awareness for a disease that is largely preventable. Colorectal cancer is now the leading cause of cancer death in adults under 50 and the only major cancer where mortality is rising in younger adults, according to a 2026 report from the American Cancer Society.
How AI is advancing medical research
Able to absorb, examine and analyze staggering amounts of data, artificial intelligence (AI) helps medical researchers identify disease patterns and predict patient outcomes.
Cell therapy for Sjögren’s disease earns FDA Fast Track designation
A therapy currently being tested in a clinical trial at the University of Wisconsin School of Medicine and Public Health to treat a common symptom of Sjögren’s disease recently got a boost from the Food and Drug Administration.
UW–Madison and Immuto Scientific to collaborate on novel cancer target discovery
University of Wisconsin–Madison and Immuto Scientific have officially entered into a collaborative agreement to identify disease-specific, novel therapeutic targets in colorectal cancer.
Q&A: Christopher Sundberg on the role of muscles in the aging process
What determines healthspan, the term used to describe the number of years people live in good health and free from chronic disease? Muscle physiology plays a key role.
Top ten research stories for 2025
The numbers are in — the end-of-year web analytics, that is — and they show robust interest in research at the UW School of Medicine and Public Health! In 2025, articles about new discoveries and one-on-one interviews with researchers were among the most-viewed stories of the year.